Prevenção primária da síndrome de Down e da doença de Alzheimer: Investigação de polimorfismos gênicos acentuadores da deposição cerebral de beta amilóide

• Autor(a) principal: Corrêa, Juliana da Cruz
• Data de Publicação: 2009
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Biblioteca Digital de Teses e Dissertações da UERJ
• Texto Completo: http://www.bdtd.uerj.br/handle/1/12763
• topic: APOE; PSEN1; TNF-α; Down syndrome; Alzheimer disease; enetic polymorphism; APOE; PSEN1; TNF-α; Síndrome de Down; Doença de Alzheimer; Polimorfismo Genético; CNPQ::CIENCIAS BIOLOGICAS::GENETICA::GENETICA HUMANA E MEDICA

The development of neuropathological changes of Alzheimer's disease (AD) in patients with Down syndrome (DS) from 40 years old and the high rate of DS births in families of DA individuals suggest a common susceptibility between the two diseases. Besides a five-fold higher risk for AD has been reported in young mothers of DS individuals. This shared genetic susceptibility involving DS and AD could be due to an accelerated ageing process, leading to the birth of a DS child in the offspring of young mothers and to an increased risk of dementia among them. Between the genetic risk factors for AD, APOE, PSEN1 and TNF-α genes are directly or indirectly involved in cerebral amyloid deposition and seem to play a role in the pathogenesis of dementia in DS. In this study, we analyzed the frequency of APOE alleles ε2, ε3 e ε4 and the polymorphisms -48C>T in the PSEN1 gene and -850C>T in the TNF-α gene in DS young mothers in comparison to mothers who had had chromosomicaly normal children. With this purpose, DNA samples were extracted from 114 mothers of DS individuals (full trisomy 21) with less than 35 years-old at conception, and from 110 control mothers. For the screening of the APOE alleles, PSEN1 -48C>T and TNF-α -850C>T polymorphisms, polymerase chain reaction (PCR) was accomplished, followed by the digestion of the amplification products with the restriction endonucleases HhaI, HgaI and HincII, respectively. The digested products were analysed by polyacrilamide gels electrophoresis followed by silver staining. No significant differences were observed between the genotype distributions observed in control and case samples with respect APOE alleles, PSEN1 -48C>T and TNF-α -850C>T polymorphisms (Fisher exact test: c2 =4,26; g.l. = 4; P =0,37; c2 =0,22; g.l. = 2; P =0,89; c2 = 4,24; g.l. = 2; P = 0,12, respectively). No differences were also observed in the gene multiplicative interaction analysis for APOE, PSEN1 and TNF-α alleles and in the interaction of these alleles with folate pathway polymorphisms (MTHFR 677C>T, MTHFR 1298A>C, MTRR 66A>G, MTR 2756A>G, RFC-1 80G>A, TC 776C>G e CBS 844ins68). This is the first study reporting the investigation of these genes in Brazilian DS mothers. Our findings suggest that APOE ε4, PSEN1 -48C and TNF-α -850T alleles are not independent risk factors for AD in young DS mothers. However, considering the complexity of both DS and AD, polymorphisms in other genes should be investigated to evaluate the actual relationship between the genetic risk factors and AD in DS young mothers.